Capital World Investors
DGX icon

Capital World Investors’s Quest Diagnostics DGX Stock Holding History

Capital World Investors’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-1,465,695
Closed -$84.9M – 518
2014
Q1 		$84.9M Sell
1,465,695
-5,250,000
-78% -$281M 0.02% 309
2013
Q4 		$360M Sell
6,715,695
-3,799,305
-36% -$225M 0.1% 187
2013
Q3 		$650M Sell
10,515,000
-3,830,000
-27% -$229M 0.2% 125
2013
Q2 		$870M Buy
+14,345,000
New +$855M 0.28% 97

Other funds holding DGX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
DSA
Davis Selected Advisers Tucson, Arizona $23.3B AUM 26.95% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital World Investors's DGX Position: Q2 2014 in Review

Capital World Investors sold out of Quest Diagnostics (DGX) in Q2 2014, closing a stake of 1,465,695 shares — an estimated $84.9M sold.

Capital World Investors first reported a position in DGX in Q2 2013 and held it in 4 quarters. The position peaked at $870M in Q2 2013. 496 funds tracked by Wall St. Rank hold DGX as of Q2 2014.

  • Capital World Investors reported no remaining Quest Diagnostics position as of Q2 2014 after selling out during the quarter.
  • Capital World Investors sold 1,465,695 Quest Diagnostics shares in Q2 2014, an estimated $84.9M.
  • Capital World Investors first reported a position in Quest Diagnostics in Q2 2013 and held it in 4 quarters.
  • Capital World Investors's Quest Diagnostics position peaked at $870M in Q2 2013.
  • 496 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2014.

Based on Capital World Investors's 13F filing for Q2 2014, filed 14 Aug 2014.